Novel pathomechanisms and therapeutic targets in neurodegenerative diseases

神经退行性疾病的新病理机制和治疗靶点

• 批准号: nhmrc : 1123564
• 负责人: Dr Yazi Ke
• 金额: $ 23.23万
• 依托单位: The University of New South Wales
• 依托单位国家: 澳大利亚
• 项目类别: Career Development Fellowships
• 财政年份: 2017
• 资助国家: 澳大利亚
• 起止时间: 2017-01-01 至 2020-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/novel-pathomechanisms-therapeutic-neurodegenerative-diseases/947191
• 关键词: Novel; pathomechanisms; therapeutic; targets; neurodegenerative

This fellowship will provide new insight into the molecular processes underlying onset and progression of common brain conditions, including Alzheimer’s disease, frontotemporal dementia and motor neuron disease. Furthermore, new therapeutic targets for these diseases will be developed and tested in model systems, to facilitate future translation into clinical application, and to overcome the lack of treatments.

该奖学金将为常见脑部疾病（包括阿尔茨海默病、额颞叶痴呆和运动神经元疾病）的发病和进展提供新的分子过程。此外，将在模型系统中开发和测试这些疾病的新治疗靶点，以促进未来转化为临床应用，并克服缺乏治疗方法的问题。